Since decreased SREBP1 protein level caused by Hsp90 inhibitors treatments could only be partially reversed by MG132, we next explored whether Hsp90 inhibitors reduced transcripts of SREBP1 in HCC cells. This evidence concerns the gene SREBF1 and hepatocellular carcinoma.